Document Detail


Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores.
MedLine Citation:
PMID:  23547265     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Our aim was to compare 2 Framingham vascular risk scores with a dementia risk score in relation to 10-year cognitive decline in late middle age.
METHODS: Participants were men and women with mean age of 55.6 years at baseline, from the Whitehall II study, a longitudinal British cohort study. We compared the Framingham general cardiovascular disease risk score and the Framingham stroke risk score with the cardiovascular risk factors, aging and dementia (CAIDE) risk score that uses risk factors in midlife to estimate risk of late-life dementia. Cognitive tests included reasoning, memory, verbal fluency, vocabulary, and global cognition, assessed 3 times over 10 years.
RESULTS: Higher cardiovascular disease risk and higher stroke risk were associated with greater cognitive decline in all tests except memory; higher dementia risk was associated with greater decline in reasoning, vocabulary, and global cognitive scores. Compared with the dementia risk score, cardiovascular and stroke risk scores showed slightly stronger associations with 10-year cognitive decline; these differences were statistically significant for semantic fluency and global cognitive scores. For example, cardiovascular disease risk was associated with -0.06 SD (95% confidence interval [CI] = -0.08, -0.05) decline in the global cognitive scores over 10 years whereas dementia risk was associated with -0.03 SD (95% CI = -0.04, -0.01) decline (difference in β coefficients = 0.03; 95% CI = 0.01, 0.05).
CONCLUSIONS: The CAIDE dementia and Framingham risk scores predict cognitive decline in late middle age but the Framingham risk scores may have an advantage over the dementia risk score for use in primary prevention for assessing risk of cognitive decline and targeting of modifiable risk factors.
Authors:
Sara Kaffashian; Aline Dugravot; Alexis Elbaz; Martin J Shipley; Séverine Sabia; Mika Kivimäki; Archana Singh-Manoux
Related Documents :
23857805 - Autism spectrum disorder in chinese populations: a brief review.
23832375 - Ascertainment of medicaid payment for delivery on the iowa birth certificate: is accura...
24774085 - Normal myocardial perfusion spect database for the spanish population.
24433635 - Predictive qualitative risk model of bovine rabies occurrence in brazil.
15740825 - Multiple stressors and coronary disease in women. the stockholm female coronary risk st...
21307725 - Occupant and crash characteristics for case occupants with cervical spine injuries sust...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Neurology     Volume:  80     ISSN:  1526-632X     ISO Abbreviation:  Neurology     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-04-02     Completed Date:  2013-05-23     Revised Date:  2014-04-02    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1300-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cognition Disorders / diagnosis*,  epidemiology,  etiology*
Dementia / complications*,  psychology
Disease Progression
Female
Humans
Longitudinal Studies
Male
Middle Aged
Neuropsychological Tests
Predictive Value of Tests
Risk Factors
Severity of Illness Index*
Grant Support
ID/Acronym/Agency:
HS06516/HS/AHRQ HHS; PG/11/63/29011//British Heart Foundation; R01AG013196/AG/NIA NIH HHS; R01AG034454/AG/NIA NIH HHS; R01HL36310/HL/NHLBI NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Seven benzimidazole pesticides combined at sub-threshold levels induce micronuclei in vitro.
Next Document:  The first steps of clinical neurology in South America.